Principal Investigator
Estelamari Rodriguez
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20221308
Clinical Trial Summary
Phase 1/1b, Multicenter, Open-Label, Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects with Advanced KRASG12C Mutant Solid Tumors
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647